Back to results

CompletedPhase 3

Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia

NCT00095719

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Local Institution

Santa Ana, California, United States

+13 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2003-12
Enrollment: 125 participants
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Purpose: treatment

Locations (14)

Local InstitutionSanta Ana, California, United States
Local InstitutionHamden, Connecticut, United States
Local InstitutionHialeah, Florida, United States
Local InstitutionMiami, Florida, United States
Local InstitutionNorth Miami, Florida, United States
Local InstitutionIndianapolis, Indiana, United States
Local InstitutionNew York, New York, United States
Local InstitutionStaten Island, New York, United States
Local InstitutionDayton, Ohio, United States
Local InstitutionOklahoma City, Oklahoma, United States
Local InstitutionTulsa, Oklahoma, United States
Local InstitutionHershey, Pennsylvania, United States
Local InstitutionAustin, Texas, United States
Local InstitutionMidvale, Utah, United States

Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia — TrialFind